Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Influence of environmental variables in the efficiency of phage therapy in aquaculture

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aquaculture facilities worldwide continue to experience significant economic losses because of disease caused by pathogenic bacteria, including multidrug-resistant strains. This scenario drives the search for alternative methods to inactivate pathogenic bacteria. Phage therapy is currently considered as a viable alternative to antibiotics for inactivation of bacterial pathogens in aquaculture systems. While phage therapy appears to represent a useful and flexible tool for microbiological decontamination of aquaculture effluents, the effect of physical and chemical properties of culture waters on the efficiency of this technology has never been reported. The present study aimed to evaluate the effect of physical and chemical properties of aquaculture waters (e.g. pH, temperature, salinity and organic matter content) on the efficiency of phage therapy under controlled experimental conditions in order to provide a basis for the selection of the most suitable protocol for subsequent experiments. A bioluminescent genetically transformed Escherichia coli was selected as a model microorganism to monitor real-time phage therapy kinetics through the measurement of bioluminescence, thus avoiding the laborious and time-consuming conventional method of counting colony-forming units (CFU). For all experiments, a bacterial concentration of ≈ 10 5 CFU ml −1 and a phage concentration of ≈ 10 6–8 plaque forming unit ml −1 were used. Phage survival was not significantly affected by the natural variability of pH (6.5–7.4), temperature (10–25°C), salinity (0–30 g NaCl l −1) and organic matter concentration of aquaculture waters in a temperate climate. Nonetheless, the efficiency of phage therapy was mostly affected by the variation of salinity and organic matter content. As the effectiveness of phage therapy increases with water salt content, this approach appears to be a suitable choice for marine aquaculture systems. The success of phage therapy may also be enhanced in non-marine systems through the addition of salt, whenever this option is feasible and does not affect the survival of aquatic species being cultured.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Population and evolutionary dynamics of phage therapy.

          Following a sixty-year hiatus in western medicine, bacteriophages (phages) are again being advocated for treating and preventing bacterial infections. Are attempts to use phages for clinical and environmental applications more likely to succeed now than in the past? Will phage therapy and prophylaxis suffer the same fates as antibiotics--treatment failure due to acquired resistance and ever-increasing frequencies of resistant pathogens? Here, the population and evolutionary dynamics of bacterial-phage interactions that are relevant to phage therapy and prophylaxis are reviewed and illustrated with computer simulations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.

            Colonization of the gastrointestinal tract with vancomycin-resistant Enterococcus faecium (VRE) has become endemic in many hospitals and nursing homes in the United States. Such colonization predisposes the individual to VRE bacteremia and/or endocarditis, and immunocompromised patients are at particular risk for these conditions. The emergence of antibiotic-resistant bacterial strains requires the exploration of alternative antibacterial therapies, which led our group to study the ability of bacterial viruses (bacteriophages, or phages) to rescue mice with VRE bacteremia. The phage strain used in this study has lytic activity against a wide range of clinical isolates of VRE. One of these VRE strains was used to induce bacteremia in mice by intraperitoneal (i.p.) injection of 10(9) CFU. The resulting bacteremia was fatal within 48 h. A single i.p. injection of 3 x 10(8) PFU of the phage strain, administered 45 min after the bacterial challenge, was sufficient to rescue 100% of the animals. Even when treatment was delayed to the point where all animals were moribund, approximately 50% of them were rescued by a single injection of this phage preparation. The ability of this phage to rescue bacteremic mice was demonstrated to be due to the functional capabilities of the phage and not to a nonspecific immune effect. The rescue of bacteremic mice could be effected only by phage strains able to grow in vitro on the bacterial host used to infect the animals, and when such strains are heat inactivated they lose their ability to rescue the infected mice.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Phage therapy: facts and fiction.

              Recent examples of the use of bacteriophages in controlling bacterial infections are presented, some of which show therapeutic promise. The therapeutic use of bacteriophages, possibly in combination with antibiotics, may be a valuable approach. However, it is also quite clear that the safe and controlled use of phage therapy will require detailed information on the properties and behavior of specific phage-bacterium systems, both in vitro and especially in vivo. In vivo susceptibility of bacterial pathogens to bacteriophages is still largely poorly understood and future research on more phage-bacterium systems has to be undertaken to define the requirements for successful phage treatments.
                Bookmark

                Author and article information

                Journal
                Microb Biotechnol
                Microb Biotechnol
                mbt2
                Microbial Biotechnology
                BlackWell Publishing Ltd (Oxford, UK )
                1751-7915
                1751-7915
                September 2014
                20 May 2014
                : 7
                : 5
                : 401-413
                Affiliations
                Departamento de Biologia & CESAM, Universidade de Aveiro, Campus Universitário de Santiago Aveiro, Portugal
                Author notes
                *For correspondence. E-mail aalmeida@ 123456ua.pt ; Tel. +351234370350; Fax +351234372587.

                Funding Information This work was supported by funding FEDER through COMPETE – Programa Operacional Factores de Competitividade, and by National funding through FCT-Fundação para a Ciência e Tecnologia (Foundation for Science and Technology), within the research project FCOMP-01-0124-FEDER-013934 and project PROMAR 31-03-05-FEP-0028. We also thank Centre for Environmental and Marine Studies, University of Aveiro (CESAM, project Pest-C/MAR/LA0017/2011) and Department of Biology of University of Aveiro where this work was done. Financial support to Silva Y.J. (SFRH/BD/65147/2009) and Pereira C. (SFRH/BD/76414/2011) was provided by the FCT in the form of PhD grants. Financial support to Costa L. was provided in the form of PI grant within the research project FCOMP-01-0124-FEDER-013934.

                Article
                10.1111/1751-7915.12090
                4229321
                24841213
                6ba1fa93-73b2-45f8-8754-05ddb6a69f08
                © 2013 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 22 March 2013
                : 02 August 2013
                : 27 August 2013
                Categories
                Research Articles

                Biotechnology
                Biotechnology

                Comments

                Comment on this article